Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex

Metabolic Brain Disease

Volumn 27, Issue 4, 2012, Pages 453-458

  Rezin, Gislaine T ^a,b   Scaini, Giselli ^a,b   Ferreira, Gabriela K ^a,b   Cardoso, Mariane R ^a,b   Gonçalves, Cinara L ^a,b   Constantino, Larissa S ^a,b   Deroza, Pedro F ^a,b   Ghedim, Fernando V ^a,b   Valvassori, Samira S ^a,b   Resende, Wilson R ^a,b   Quevedo, João ^a,b   Zugno, Alexandra I ^a,b   Streck, Emilio L ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

Author keywords

Acetylcholinesterase; Behavioral; Fenproporex; Memory

Indexed keywords

ACETYLCHOLINESTERASE; FENPROPOREX;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIORAL SCIENCE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MEMORY CONSOLIDATION; NONHUMAN; PREFRONTAL CORTEX; RAT; TASK PERFORMANCE;

ACETYLCHOLINESTERASE; AMPHETAMINES; ANIMALS; APPETITE DEPRESSANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOENZYMES; MALE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84871405157     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9331-9     Document Type: Article

References (49)

1. Appleyard ME (1992) Secreted acetylcholinesterase: non-classical aspects of a classical enzyme. Trends Neurosci 15:485-490
2. Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S (2005) Cholinesterases: Roles in the brain during health and disease. Curr Alzheimer Res 2:307-318
3. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-414
4. Berman JA, Talmage DA, Role LW (2007) Cholinergic Circuits and signaling in the pathophysiology of Schizophrenia. Int Rev Neurobiol 78:193-223
5. Bray GA, Tartaglia LA (2000) Medicinal strategies in the treatment of obesity. Nature 404:672-677
6. Cody JT, Valtier S, Stillman S (1999) Amphetamine and fenproporex levels following multidose administration of fenproporex. J Anal Toxicol 23:187-194
7. Coutts RT, Nazarali AJ, Baker GB, Pasutto FM (1986) Metabolism and disposition of N-(2-cyanoethyl)-Amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol 64:724-728
8. Cragg SJ (2006) Meaningful silences: How dopamine listens to the ACh pause. Trends Neurosci 29:125-131
9. Das A, Kapoor K, Sayeepriyadarshini AT, Dikshit M, Palit G, Nath C (2000) Immobilization stress-induced changes in acetylcholinesterase activity and cognitive function in mice. Pharmacol Res 42:213-217
10. Ellman GI, Courtney KD, Andres V Jr, Feather-Stone RM(1961) A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochem Pharmacol 7:88-95
11. Gilboa-Geffen A, Hartmann G, Soreq H (2012) Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions. Front Mol Neurosci 5:30. doi:10.3389/fnmol.2012.00030
12. Gotti C, Clementi F (2004) Neuronal nicotinic receptors: From structure to pathology. Prog Neurobiol 74:363-396
13. Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H (1999) Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 264:672-686
14. Gurevich-Panigrahi T, Panigrahi S, Wiechec E, Los M (2009) Obesity: Pathophysiology and Clinical Management. Curr Med Chem 16:506-521
15. Hyde TM, Crook JM (2001) Cholinergic systems and schizophrenia: Primary pathology or epiphenomena? J Chem Neuroanat 22:53-63
16. Klegeris A, Korkina LG, Greenfield SA (1995) A possible interaction between acetylcholinesterase and dopamine molecules during autoxidation of the amine. Free Radic Biol Med 18:223-230
17. Kleijn J, Wiskerke J, Cremers TI, Schoffelmeer AN, Westerink BH, Pattij T (2012) Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation. Neurochem Int. Mar 10. [Epub ahead of print]
18. Kraemer T, Theis GA, Weber AA, Maurer HH (2000) Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatographymass spectrometry and fluorescence polarization immunoassay. J Chromatogr B 738:107-118
19. Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. J Neurochem 68:2032-2037
20. Kuczenski R, Segal DS (2001) Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine. J Pharmacol Exper Ther 296:876-883
21. Kuczenski R, Segal DS (2002) Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22:7264-7271
22. Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR (1999) In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52:691-699
23. LaVoie MJ, Hastings TG (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19:1484-1491
24. Liu J, Olivier K, Pope CN (1999) Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats. Toxicol Appl Pharmacol 158:186-196
25. Lowry OH, Rosebough NG, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
26. Mattei R, Carlini EA (1996) Acomparative study of the anorectic and behavioral effects of fenproporex on male and female rats. Braz J Med Biol Res 29:1025-1030
27. Mesulam MM (2004) The cholinergic innervation of the human cerebral cortex. Progr Brain Res 145:67-78
28. Milatovic D, Dettbarn WD (1996) Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat. Toxicol Appl Pharmacol 136:20-28
29. Moser VC, Padilla S (1998) Age-And gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol Appl Pharmacol 149:107-119
30. Moussavi N, Gavino V, Receveur O (2008) Could the Quality of Dietary Fat, and Not Just Its Quantity, Be Related to Risk of Obesity? Obesity 16:7-15
31. Musial A, Bajda M, Malawska B (2007) Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem 14:2654-2679
32. Namba H, Iyo M, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, Sudo Y, Suzuki K, Irie T (1999) Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age. Eur J Nucl Med 26:135-143
33. Page G, Peeters M, Najimi M, Maloteaux JM, Hermans E (2001) Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes. J Neurochem 76:1282-1290
34. Rezin GT, Jeremias IC, Ferreira GK, Cardoso MR, Morais MO, Gomes LM, Martinello OB, Valvassori SS, Quevedo J, Streck EL (2011) Brain energy metabolism is activated after acute and chronic administration of fenproporex in young rats. Int J Dev Neurosci 29:937-942
35. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198
36. Roesler R, Vianna MR, De-Paris F, J Q (1999) Memory-enhancing treatments do not reverse the impairment of inhibitory avoidance retention induced by NMDA receptor blockade. Neurobiol Learn Mem 72:252-258
37. Sarter M, Parikh V (2005) Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6:48-56
38. Schetinger MRC, Porto NM, Moretto MB, Morsch VM, Rocha JBT, Vieira V, Moro F, Neis RT, Bittencourt S, Bonacorso HG, Zanatta N (2000) New benzodiazepines alter acetylcholinesterase and ATP-Dase activities. Neurochem Res 25:949-955
39. Silman I, Sussman JL (2005) Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Curr Opin Pharmacol 5:293-302
40. Smythies J (2005) Section I: The cholinergic system. Int Rev Neurobiol 64:1-122
41. Spina MB, Cohen G (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Natl Acad Sci USA 86:1398-1400
42. Steriade M (2004) Acetylcholine systems and rhythmic activities during the waking-sleep cycle. Prog Brain Res 145:179-196
43. Tse MT, Cantor A, Floresco SB (2011) Repeated amphetamine exposure disrupts dopaminergic modulation of amygdala-prefrontal circuitry and cognitive/emotional functioning. J Neurosci 31 (31):11282-94
44. United Nations International Narcotics Control Board (UNINCB). Report of the International Narcotics Control Board for 2007 (E/INCB/2007/ 1). Available at: http://www.incb.org/incb/annual-report-2007.html.
45. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L (2001) Therapeutic doses of oral methylphenidate significantly increases extracellular dopamine in the human brain. J Neurosci 2:121-125
46. Wonnacott S, Sidhpura N, Balfour DJ (2005) Nicotine: From molecular mechanisms to behavior. Curr Opin Pharmacol 5:53-59
47. Woolf N (1991) Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37:475-524
48. Zheng Q, Olivie, K, Won YK, Pope CN (2000) Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats. Toxicol Sci 55:124-132
49. Zhu J, Reith ME (2008) Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol Disord Drug Targets 7:393-409